October 14, 2016 / 6:02 PM / in a year

BRIEF-Valeant announces price changes for neurology, GI, urology portfolis

Oct 14 (Reuters) - Valeant Pharmaceuticals International Inc :

* Valeant Patient Access and Pricing Committee comments on recent pricing action decisions

* Patient Access and Pricing Committee has made decisions regarding price changes of products in company’s neurology, GI and urology portfolios

* Planned wholesale acquisition price changes, effective October 14, range from 2.0 percent to 9.0 percent

* There will be no pricing adjustments this year on dermatology and ophthalmology products

* 2016 pricing actions across its U.S. branded RX portfolio, represent an increase of less than 2.0 percent within calendar 2016 year Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below